Kevin Kotler’s Broadfin Capital Reveals New Stake in Dipexium Pharmaceuticals (DPRX)

A new filing with the SEC, Kevin Kotler and his hedge fund Broadfin Capital revealed new stake in Dipexium Pharmaceuticals, Inc (NASDAQ:DPRX). In Dipexium Pharmaceuticals, Kevin Kotler currently owns a total of 475,000 shares, which make the holding equal to 5.85% of the common stock.

Kevin Kotler

Dipexium Pharmaceuticals, Inc (NASDAQ:DPRX), founded in 2010, develops and commercializes Locilex, a peptide topical antibiotic, to treat mild or moderate acute bacterial skin and skin structure infections in superficial wounds. Formerly, the emerging biotechnology company was known as Dipexium Pharmaceuticals, LLC.

Last month, the company closed its initial public offering of approximately 3.2 million shares at an offer price of $12.0 per share. Dipexium raised net proceeds of approximately $35.1 million and the biotechnology company plans to use the net proceeds to further develop its antibiotic, Locilex. A couple of days ago, the Oppenheimer initiated coverage on Dipexium with an ‘outperform’ rating at a target price of $27.0 per share.

In February, Dipexium Pharmaceuticals, Inc (NASDAQ:DPRX) entered into a partnership with RRD International LLC, a provider of product development and expert-level support services to biopharmaceutical companies and investors, to develop Locilex.

Broadfin Capital is located in New York City. The fund has an equity portfolio of $758.2 million, concentrated in the Healthcare sector. Kevin Kotler, the founder of the fund has worked with The Galleon Group, ABN AMRO, and ING Barings.

Broadfin Capital has been active in the recent couple of months, reporting new stakes in several companies. Last month, the fund initiated position in Pernix Therapeutics (NASDAQ:PTX), with 3.5 million shares. In January, the fund disclosed holding a 6.9% stake in Retrophin Inc (NASDAQ:RTRX), which contains 1.61 million shares.

According to the fund’s latest 13F, top holdings of Broadfin Capital, as at the end of last year, were Depomed Inc (NASDAQ:DEPO), with a stake valued in excess of $50.2 million, followed by Lannett Company, Inc. (NYSE:LCI), of which it held around 1.3 million shares worth $44.4 million, and Angiodynamics Inc (NASDAQ:ANGO), in which it owned 2.5 million shares valued at more than $42.8 million.

Disclosure: none

Recommended Reading:

Kevin Kotler’s Broadfin Capital’s and MELA Sciences (MELA)

Kevin Kotler’s Broadfin Capital Initiates Stake in Eleven Biotherapeutics (EBIO) Following Its IPO

Broadfin Capital Ups Position in Rigel Pharmaceuticals, Inc. (RIGL)

blog comments powered by Disqus
Insider Monkey Headlines
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months Click to see monthly returns in table format!

Lists

10 Best States To Practice Medicine

The 10 Best States to Have a Business

The 12 Most Expensive Apple (AAPL) Apps in the Market

The 10 Richest Billionaires in the World

10 Biggest Kickstarter Failures

The 10 Best Places to Work At

The Top 10 of Google Inc (GOOGL)’s Most Expensive Acquisitions

13 Best Cities to Visit in South America

10 Most Expensive Works of Art of All Time

The 10 Richest Banks in the World

The 10 Best-Paying Jobs in America (2014)

7 Most Expensive Foods in the World

The World’s Top 10 Earning Authors

Five Wicked and Very Expensive Items (and Other “Stuff”) Sold on eBay

10 Biggest Celebrity Bankruptcies

The Top 10 Highest Paid CEOs in 2014

The 10 Most Expensive Real Estate Cities in America

10 Most Expensive States To Live In America

The 10 Best Airlines in the World

The 10 Best-Selling Cars in 2014

The 10 Best Industries to Invest In

The 10 Most Expensive States to Own a Car In

Top 10 Business Schools in US: 2014 Rankings

Top 20 Female Billionaires in 2014

6 Movies That You Should Watch to Better Understand The Cold War

Top 15 Best Paying Jobs for Women in 2014

Top 6 Things Rich People Do Differently Every Day

5 Retirement Mistakes To Avoid (and Einstein’s Famous Quote)

11 Smartest People in the World

6 Films About the Financial World You Need To Watch (While “The Wolf” is Not Around)

Warren Buffett and Billionaires Are Crazy About These 7 Stocks

The Top 10 States With Fastest Internet Speeds

10 Best Places to Visit in USA in August

Top 10 Cities to Visit Before You Die

Top 10 Genetically Modified Food In the US

15 Highest Grossing Movies Opening Weekend

5 Best Poker Books For Beginners

10 Strategies Hedge Funds Use to Make Huge Returns

Top 10 Fast Food Franchises to Buy

10 Best Places to Visit in Canada

Best Summer Jobs for Teachers

10 Youngest Hedge Fund Billionaires

Top 10 One Hit Wonders of the 90s

Fastest Growing Cities In America

Top 10 U.S. Cities for Freelancers

Top 9 Most Popular Free iPhone Apps

Top 10 Least Expensive Private Business Schools in the US

Top 15 Most Expensive Countries in the World – 2014

Top 6 Tax Scams and How to Protect Yourself

Top Businesses to Invest In

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!